Department of Immunology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.
Department of Computational Biophysics and Bioinformatics, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.
Cytokine Growth Factor Rev. 2016 Apr;28:79-93. doi: 10.1016/j.cytogfr.2015.12.001. Epub 2015 Dec 15.
Secretory leukocyte protease inhibitor (SLPI), a ∼12kDa nonglycosylated cationic protein, is emerging as an important regulator of innate and adaptive immunity and as a component of tissue regenerative programs. First described as an inhibitor of serine proteases such as neutrophil elastase, this protein is increasingly recognized as a molecule that benefits the host via its anti-proteolytic, anti-microbial and immunomodulatory activities. Here, we discuss the diverse functions of SLPI. Moreover, we review several novel layers of SLPI-mediated control that protect the host from excessive/dysregulated inflammation typical of infectious, allergic and autoinflammatory diseases and that support healing responses through affecting cell proliferation, differentiation and apoptosis.
分泌白细胞蛋白酶抑制剂 (SLPI) 是一种约 12kDa 的非糖基化阳离子蛋白,它作为先天和适应性免疫的重要调节剂以及组织再生程序的组成部分而崭露头角。该蛋白最初被描述为一种丝氨酸蛋白酶抑制剂,如中性粒细胞弹性蛋白酶的抑制剂,现在人们越来越认识到它是一种通过其抗蛋白酶、抗微生物和免疫调节活性有益于宿主的分子。在这里,我们讨论了 SLPI 的多种功能。此外,我们还回顾了 SLPI 介导的控制的几个新层面,这些控制可以保护宿主免受感染、过敏和自身炎症性疾病中典型的过度/失调的炎症,并通过影响细胞增殖、分化和凋亡来支持愈合反应。